Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02328859 · ClinicalTrials.gov registry record · Early Phase 1

Virtual Reality Rehabilitation for Individuals With Lower Limb Amputation

A Early Phase 1 study, sponsored by VA Office of Research and Development.

Completed
Registry status
Early Phase 1
Development phase
4
Enrollment target

NCT02328859: Completed Early Phase 1 study, sponsored by VA Office of Research and Development.

NCT02328859 is a Early Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 4 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02328859, a Early Phase 1 study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
Early Phase 1
Development phase
4 participants
Enrollment target

Study Summary

A custom designed Virtual Gait Retraining System (VGRS) is being adapted for balance and mobility rehabilitation in individuals with transtibial amputation. The system is composed of a treadmill that can simulate different environmental situations such as walking up stairs and hills and going around curves. The treadmill is synchronized with an immersive display and an avatar of the user. The combination of variable terrain and visual feedback is extremely promising as a means for amputee patients to achieve improved functional mobility after gait training. The proposed work is relevant to public health because it is the first step in developing a novel rehabilitation system that will use visual feedback for gait training in amputees and others with pathological gait disorders. The research is pertinent to the mission of the Department of Veterans Affairs which is committed to improve the quality of life of Veterans with disability.

Primary Outcome

Knee joint symmetry will be determined by joint loading (knee joint moments). Changes in joint loading will be measured as the difference in knee joint moment between the left and right leg (measured in Newtons/meter/kilogram of body weight).

Interventions

  • OTHER Virtual Reality Gait Training
  • OTHER Treadmill Gait Training

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2016-04-01
Est. Completion 2017-06-27
Phase Early Phase 1
VA Office of Research and Development

1,668 total trials

What the finished NCT02328859 record still lists

NCT02328859 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Virtual Reality Gait Training is the first listed.

NCT02328859 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02328859 about?

NCT02328859 is a clinical study titled "Virtual Reality Rehabilitation for Individuals With Lower Limb Amputation". A custom designed Virtual Gait Retraining System (VGRS) is being adapted for balance and mobility rehabilitation in individuals with transtibial amputation. The system is composed of a treadmill that can simulate different environmental situations such as walking up stairs and hills and going around...

What is the current status of trial NCT02328859?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2016-04-01. Estimated completion is 2017-06-27.

What interventions are being tested in trial NCT02328859?

The interventions under investigation include: Virtual Reality Gait Training (OTHER), Treadmill Gait Training (OTHER).

Who is sponsoring clinical trial NCT02328859?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02328859's enrollment target sits among peer trials

4 1922nd of 2000 higher than 53 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02328859, the US trial registry maintained by the National Library of Medicine. NCT02328859 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.